Clinical Trial News Archive
Get news by email or subscribe to our news feeds.
News Archive for August 2007
August 1, 2007
- Iomai to Announce Positive Results from Phase 2 Field Trial of Its Travelers Diarrhea Vaccine and Host Conference Call and Webcast Tomorrow
- Success or Failure of Antidepressant Citalopram Predicted by Gene Variation
- Phase II Study of Therapeutic Vaccine Shows Efficacy in Patients with Metastatic Colorectal Cancer
- Canopus BioPharma's StatC Drug Shows Superior Results for Treatment of Avian Flu and Other Influenzas
- Sarasota's Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
August 2, 2007
- Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
- Encore Therapeutics Inc. (ETI) Reports Additional Proof of Concept Results on its Extended Release Ropivacaine Injectable Gel for Postoperative Pain Management
- Mayo Clinic News Release: "Wake-Up Pill" Under Study to Treat Patients with Bipolar Disorder
- Study provides hope for patients battling obesity and psoriasis
- Cobalis Reports PreHistin Demonstrates Significant Potential for Treatment of Vitamin B12 Deficiency
- Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
- Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
- Progesterone Therapy and Preterm Birth: More Evidence Helps Identify Women Who Can Benefit
- Pulmonary Fibrosis Mortality Rates Continue to Increase, Especially in Women
- Generex Biotechnology to Exhibit At American Association of Diabetes Educators Annual Meeting & Exhibition
- Oxford Biomedica: Publication of Trovax Phase II Clinical Trial Data
- Side Effects of New Drug for High-Risk Breast Cancer Are Manageable
- Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
August 3, 2007
- Landmark Study in The Lancet: Patients Treated With Betaseron After First MS Attack Experienced Significant Delay in MS Progression
- Patients Treated with Betaferon After First MS Attack Experienced Significant Delay in Disability Progession
August 6, 2007
- NanoViricides, Inc. Presents at the BARDA Industry Day
- Molecular Insight Pharmaceuticals, Inc. Selected to Present Zemiva Phase 2b Clinical Trial Data in Late Breaking Clinical Forum at American Society of Nuclear Cardiology Annual Meeting
- MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
- Apollo’s Trial Success - Needle-free Drug Delivery
August 7, 2007
- Arpida Presents a Large Body of Preclinical and Clinical Data at Scientific Conferences
- Deflux Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
- EPIX Pharmaceuticals Announces Positive Results from Phase 2a Clinical Trial of First-in-Class 5-HT2B Antagonist in Patients with Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease
- Hydra Biosciences Announces Data Revealing the Crucial Role Played by the TRPA1 Ion Channel in a Standard Model of Pain Receptor Activation
- JCEM Publishes Data from OXiGENE-sponsored Preclinical Study of Combretastatin A4 phosphate / CA4P Triple-Drug Combinations in Anaplastic Thyroid Cancer
- Researchers at Cleveland Clinic Identify Site of 'Dysfunction' in HDL, Carrier of Good Cholesterol
- Gene Predicts Better Outcome as Cortex Normalizes in Teens with ADHD
- Peregrine's Bavituximab HCV Phase Ib Study Results Selected for Oral Presentation at Upcoming AASLD Annual Meeting
August 8, 2007
- FermaVir Announces Positive Data from Recent Preclinical Studies of FV-100
- Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
- CytoDyn DNA Vaccine Shows Promise for Low-Dose Protection from Bird Flu, Reliable Supply
- Nutra Pharma Announces Positive Results of ReceptoPharm Pain Study
- Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
August 9, 2007
- Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
- Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers' Diarrhea Patch Vaccine
- InNexus Biotechnology to Host Teleconference/Web Cast Outlining Recently Launched Pre-Clinical Candidate DXL625 (CD20)
- Prophylactic Use of Recombinant Factor VIII Prevents Joint Disease in Young Boys with Hemophilia A
- Obesity Linked to Hyperparathyroidism in Chronic Kidney Disease
- DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
August 13, 2007
- Positive Kuvan Pivotal Phase 3 Trial Results Published in The Lancet
- Newly Published Research Indicates the Potential of Phenoxodiol to Protect Against Neuropathy
August 14, 2007
- Idera Pharmaceuticals Announces Publication of Preclinical Data on Toll-Like Receptor 7 and 8 Agonists
- Furamidine Found to Inhibit a Key Enzyme Involved in Cancer Cell DNA Repair Mechanisms
- Phase II Clinical Trial Results for Adentri Published in Journal of the American College of Cardiology
- BrainStorm Cell Therapeutics on the Road to Clinical Studies in Parkinson's Disease
- Oramed Pharmaceuticals Successfully Completes Phase 1A Trials
- NeurAxon Announces Positive Phase 1 Trial Data on NXN-188 for Migraine
- Generex Biotechnology Announces Publication of Generex Oral-Lyn Study Results in Diabetes Technology & Therapeutics
August 15, 2007
- Accentia Biopharmaceuticals Updates Interim Analysis of Blinded Clinical Results in the Fast-Tracked Pivotal Phase 3 Trial of SinuNase for the Treatment of Refractory Chronic Sinusitis
- Novavax Announces Publication of HIV/AIDS Vaccine Research in Journal of Virology
August 16, 2007
- Cephalon Announces Positive Results from a Pivotal Study of Fentora in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
- Novel Technology Breaks Through Cancer Pain
- Study Reports Epratuzumab Affects B-Cells from Patients With Lupus in a Unique Manner
August 17, 2007
- MediciNova Reports Phase Ib Clinical Study Results for MN-221, a Novel Treatment for Preterm Labor
- Management to Make Two Presentations on the Topic of Drug Repurposing and Indian Clinical Trial Strategy
August 20, 2007
- PNH Patients Treated with Soliris Experienced Dramatic Reduction in Blood Clots During Clinical Trials
- Intellect Neurosciences, Inc. to Present Data on Alzheimer's Vaccine at 13th International Congress of Immunology Conference
- Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge) in Advanced Breast Cancer Patients
- Adnexus Therapeutics to Present Data on Adnectin Product Candidate, CT-322, at Gordon Research Conference
- Tysabri Demonstrates Significant Health-Related Quality-of-Life Improvements for Multiple Sclerosis Patients in Study Published in Annals of Neurology
- Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab, in Non-Human Primates
- Metabasis Therapeutics Presents Preclinical Results Demonstrating Potential Advantages of MB07811 as a Treatment for Hyperlipidemia
- Can-Fite Successfully Completes Preclinical Trials With Its Second Drug Candidate CF102
- Intercell’s Therapeutic Hepatitis C Vaccine Meets Primary Endpoints in Phase II Interim Analysis
August 21, 2007
- New Data Suggest Cymbalta Reduced Pain in Fibromyalgia Patients With and Without Depression
- Nymox Announces New Clinical Data from BPH Drug Trials to Be Presented at Upcoming U.S. Urology Meeting
August 22, 2007
- CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
- Merck Serono Announces 18-Month Safety and Efficacy Dataof Phase III Trial of Safinamide in Parkinson's Disease
- Two Separate Studies Presented at the AIDS Vaccine 2007 Conference Show Improved Results with the Biojector(R)2000
- SemBioSys Updates Apo AI Development Program
- Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
- Data on PolyMedix Antimicrobial Polymers Being Presented at Annual Meeting of the American Chemical Society
- Paper in International Journal of Oncology Reports Alfacell's Onconase Suppresses Intracellular Oxidative Stress
August 23, 2007
- ProNAi Therapeutics Announces First DNAi Mechanism of Action Studies for PNT2258 Oncology Drug Candidate
- Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
- Encouraging Phase II Data on HIV Vaccine Utilizing GenVec Technologies Presented at Seattle AIDS Conference
- Iomai Announces Data from Phase 2 Field Study of Travelers' Diarrhea Vaccine Accepted for Presentation at ICAAC
- CollaGenex Pharmaceuticals Announces Highly Positive Results of Phase 2 Dose-Finding Trial of Col-118 for the Treatment of Erythema
- Opexa to Present Proprietary T-Cell Technology at Vaccine Conference on August 24, 2007
- ReGen Therapeutics Plc - Research Update
- Multiple NIH Phase 2 HIV Vaccine Trials Using Vical's Technology Produce Encouraging Results
- ZymoGenetics Will Hold Conference Call Today at 5:00 p.m. Eastern Time to Provide Update on rThrombin
- Paper in Advances in Experimental Medicine and Biology Reports Alfacell's Onconase Enhances Effect of Radiation in Non-Small Cell Lung Cancer
- MedImmune's Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
August 24, 2007
August 27, 2007
- Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
- Ascenta Therapeutics Presents New Clinical Data on AT-101 for the Treatment of Hormone-Refractory Prostate Cancer
- New Data Highlights Long Term Tolerability and Sustained Benefits of the Exelon Patch in the Treatment of Alzheimer’s Disease
- New Study May Explain Vioxx Side-effects
- Adnexus Therapeutics Announces Additional Phase I and Preclinical Data on CT-322 at 6th International Congress on Targeted Therapies in Cancer
- Actelion to Discuss Results from the Early, Compass-1, Future and Benefit Studies Presented at the European Society of Cardiology Congress
- Actelion to announce results from 'proof-of-concept'/dose ranging study of its novel orexin receptor antagonist during the 2007 World Sleep Congress
- Is it Safe to Use Oral Contraceptives to Eliminate Periods? Harvard Women's Health Watch Explores the Question
- Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
- ImmuneRegen BioSciences, Inc. Demonstrates Radilex Increases Disease-Fighting White Blood Cells
- Geron Scientists and Collaborators Demonstrate Human Embryonic Stem Cell-Derived Cardiomyocytes Improve Heart Function When Transplanted After Myocardial Infarction
- NIH Scientists Discover Novel Cause of Iron Overload in Thalassemia Disorders
August 28, 2007
- Antares Pharma Will Present Anturol at the 28th Annual Scientific Meeting of the American Urogynecologic Society
- Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
- Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
- New Kaiser Permanente Study Shows Treating Diabetes During Pregnancy Can Break Link to Childhood Obesity
- Allergy Patients Treated with PreHistin Had Rise in Ragweed IgE Antibodies Blunted During Pollen Season
- Prodest Study Shows Many Parkinson’s Disease Patients Continue to Experience PD-Related Depressive Symptoms Despite Receiving Anti-Depressant Treatment
- Journal of American College of Cardiology Publishes Positive Findings on Generx Now in Phase 3 for Heart Disease
August 29, 2007
- Phase III Trial Finds Pharmaxis' Bronchitol Effective
- I-Flow Corporation Announces That Results of ON-Q Colorectal Study Will Be Presented at Infectious Diseases Conference in September
- Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
- Experimental Drug Ketasyn Improves Memory in Age-Associated Memory Impairment Study
- New Data on AtheroGenics AGI-1067 Accepted for Presentation at the European Society of Cardiology Congress 2007
- Another Step on the Journey to Hope for MDS Patients: New Study Demonstrates Survival Benefit in Patients with MDS (myelodysplastic syndromes)
August 30, 2007
- Genzyme Announces Publication of DCOR Study in Kidney International
- St. Jude Discovers Factors That Accelerate Resistance to Gleevec Targeted Therapy in Lymphoblastic Leukemia
- Transition Therapeutics Announces Completion of Phase I Clinical Studies with Alzheimer's Disease Drug Candidate ELND-005/AZD-103
- Pharming Presents Positive Results from European Phase III Trial of Rhucin
- Obecure Phase II Trial Shows Positive Results For Histalean In Obese Women Under 50
- Mayo Clinic Research Shows Estrogen Protects Women's Brains Prior to Menopause; Ovary Removal Before Menopause Increases Risk of Parkinson's Disease and Parkinsonism
